Schedule 13G ownership disclosure
Kintara Therapeutics, Inc.
Security class unavailable · CUSIP: 49720K101
Event date: 2022-04-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-22-000809
- Form type
- SC 13G
- Filer
- TuHURA Biosciences, Inc./NV
- CIK
- CIK 1498382
- Filed
- Apr 20, 2022
- Reporting period
- Apr 14, 2022
- Description
- Schedule 13G beneficial ownership